Orazamide
| Code | Size | Price |
|---|
| TAR-T21194-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Orazamide may be useful to treat chronic hepatitis and various skin diseases.
CAS:
2574-78-9
Formula:
C9H10N6O5
Molecular Weight:
282.216
Purity:
0.98
SMILES:
NC(=O)c1nc[nH]c1N.OC(=O)c1cc(=O)[nH]c(=O)[nH]1
References
1. Chen X, Jing J, Ren W, Han DE, Jing N, Wang G. Determination of 5-aminoimidazole-4-carboxamide in human plasma by ion-pair extraction and LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Aug 15;855(2):140-4. Epub 2007 May 10. PubMed PMID: 17561451.
2. P?r A, Pa?l M, K?das I, Nagy I, Kerekes E, J?vor T. Experiences with Catergen treatment in chronic active hepatitis. Ther Hung. 1983;31(3):105-14. PubMed PMID: 6400472.
3. Roda E, Sama C, Festi D. [Controlled clinical evaluation of the therapeutic effectiveness of AICA orotate in chronic hepatitis]. Clin Ter. 1979 Jun 15;89(5):489-93. Italian. PubMed PMID: 535326.
4. MIYAZAWA T, KUMASAKA S. [THE PHARMACOLOGICAL ACTIVITY OF AICA OROTATE IN VARIOUS SKIN DISEASES]. Hifuka Kiyo. 1965 Feb;60:76-84. Japanese. PubMed PMID: 14286713.